Bayer, Tel Aviv University Test Drugs on 3D-Printed Hearts

The Fellowship  |  July 14, 2020

Tel Aviv University campus landscape
Tel Aviv University campus landscape

Last year, we told you about how Israeli researchers at Tel Aviv University discovered how to print a human heart with cells and blood vessels. Now scientists will be able to perform cardiotoxicity screening reports Israel21c:

Human heart tissues 3D-printed in Tel Aviv University Prof. Tal Dvir’s Laboratory for Tissue Engineering and Regenerative Medicine will be used to test the cardiotoxicity of experimental drugs according to a collaboration agreement between the university’s tech-transfer company, Ramot, and pharmaceutical giant Bayer.

“We are excited to start this new collaboration with Tel Aviv University, which will address a new area of early assessment of safety and tolerability of drug candidates,” said Eckhard von Keutz, head of Translational Sciences at Bayer.

Stay informed about issues affecting Israel, the Jewish people, Jewish-Christian relations, receive daily devotionals, and more.